This project will recruit an intern to develop appropriate methodologies in order to assess the effectiveness of an occupational mental health promotion program that uses a blended format of in-person sessions and online learning. The intern will work closely with the industry partner to review, develop, and pilot assessment tools, oversee the data collection, analyze […]

The project goal is to determine the clinical utility of Orpyx LogR technology to detect gait changes and their efficacy to predict and monitor fall risk. Project I will use existing data to determine sensitivity and specificity for prospective classification of fallers and non-fallers for a composite measure drawn from an extensive battery including single […]

Tobacco is the number one cause of lung disease and death in Canada, and Nova Scotia in particular. For this reason, tobacco control is the number one priority for the Lung Association of Nova Scotia. To maximize the impact of its initiatives, the Lung Association of Nova Scotia is interested in collaborating with the post-doctoral […]

Memory impairment is the most common complaint associated with aging. Promising interventions based on research are generally reserved for clinical settings. Technological advancement has now made it possible to administer neurofeedback, an established technique for self-regulating brain waves, using portable technology. xSensa Labs, the partner organization, has developed a digital solution that translates research protocols […]

Small surgical instruments can be used multiple times if cleaned properly after each surgery. At the end of the cleaning process, a visual inspection of each instrument is performed in order to detect any traces of soil such as blood, tissue or any other biological materials. However, the human eye is not a flawless sensor […]

Cancer cells are nearly impossible to distinguish from normal tissue without sophisticated detection methods and conventional methods fail to provide real-time information during the surgical procedure. ODS Medical is developing an exclusive Raman spectroscopy system that collects data through an optical probe and is interfaced with sophisticated machine learning algorithm to identify tissues abnormalities in […]

In the current functional and structural neuroimaging project, we aim to identify functional and structural changes that correlate with disease presence and its severity (staging) and that can serve as a basis for future development of PD neuroimaging biomarkers. To achieve this objective we will use our expertise in functional neuroimaging of the cervical spinal […]

This project will use a breakthrough brainwave technology to track the recovery of patients who have serious brain injury after cardiac arrest. Doctors currently rely on behaviour-based tests at the patient’s bedside to measure their brain function, but this is not reliable. A better method is to measure brain function directly using brainwave information. We […]

Approximately nine million Canadians live with vision loss that, even when wearing corrective lenses, impedes their ability to perform everyday tasks. Canadians with vision loss are at greater risk of social isolation and reduced community participation. Vision loss rehabilitation (VLR) is a multi-disciplinary service that includes orientation and mobility training, independent living skills and low […]

One in every five people will develop liver disease in their lifetime. Few people think about liver disease until the disease has progressed and has permanently damaged the liver. Fatty liver disease falls into this category with obesity as the most common cause. Given more than 50% of Canadians are overweight and 75% of obese […]

Funded through a series of NSERC partnership grants, Cubresa Inc. have been working with the applicants to develop technologies for pre-clinical imaging for positron emission tomography (PET) imaging and PET friendly radiofrequency (RF) coils for magnetic resonance imaging (MRI) of small animals. To date, our collaboration has played a direct role in Cubresa being the […]

Pascal Biosciences Inc. is a company developing immuno-oncology therapeutics to fight cancer. It was initially founded on ideas and research that originated from Dr. Wilf Jefferies’ laboratory at the University of British Columbia. Since then, the company has continued to collaborate with Dr. Jefferies and his team to forward the research, through direct sponsorship and […]